Navigation Links
ViroPharma Incorporated Reports Second Quarter 2009 Financial Results
Date:7/29/2009

ermining non-GAAP net income goodwill write off and gain on extinguishment of repurchased bonds are excluded.

                        VIROPHARMA INCORPORATED
                    Selected Financial Information



    Selected Consolidated Balance Sheet Data  June 30,   December 31,
                                              --------   -----------
    (in thousands)                               2009       2008*
                                                 ----       ----

    Assets
    Current assets:
      Cash and cash equivalents                 $267,171   $275,839
      Deferred income taxes                       14,650     24,094
      Total current assets                       364,540    360,880
      Intangible assets, net                     632,012    639,693
      Goodwill                                         -     65,099
      Total assets                             1,016,125  1,086,129

    Liabilities and Stockholders' Equity
      Total current liabilities                  $36,816    $43,467
      Deferred tax liabilities                   129,632    128,254
      Long-term debt                             135,254    161,003
      Total liabilities                          304,480    336,795
      Total stockholders' equity                 711,645    749,334
      Total liabilities and stockholders'
       equity                                  1,016,125  1,086,129

    * 2008 reflects Retrospective application of FSP APB 14-1;
     see explanation on prior page

                                                 Six months ended
                                               June 30,    June 30,
                                               -------     -------
    Statement of Cash Flows:                      2009       2008
    (in thousands)                                ----       ----
    Net cash provided by operating activities  $15,868    $50,327
    Net cash (used
'/>"/>
SOURCE ViroPharma Incorporated
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related medicine news :

1. ViroPharma to Release 2009 Second Quarter Financial Results on July 29, 2009
2. ViroPharma Announces Appointment of Frank Baldino, Jr., Ph.D. to Board of Directors
3. ViroPharma Announces Meeting of FDA Advisory Committee for Pharmaceutical Science and Clinical Pharmacology on Bioequivalence Recommendations for Oral Vancomycin Hydrochloride Products
4. ViroPharma to Present at Two May Healthcare Conferences
5. ViroPharma to Present at the Cowen & Company 29th Annual Healthcare Conference
6. ViroPharma to Host Investor Teach-In Educational Symposium on Hereditary Angioedema
7. ViroPharma to Release 2008 Fourth Quarter and Full Year Financial Results on February 24, 2009
8. ViroPharma Reports Results of Phase 3 Clinical Trial for Maribavir in Bone Marrow Transplant Patients
9. ViroPharma to Present at the 27th Annual J.P. Morgan Healthcare Conference
10. ViroPharma Provides Update on Vancocin(R)
11. ViroPharma Submits Supplemental Biologics License Application for Cinryze(TM) to Treat Acute Attacks of Hereditary Angioedema
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... Line: Less than 42 percent of women underwent ... the factors associated with foregoing reconstruction included being ... older. , Author: Monica Morrow, M.D., of the ... colleagues. , Background: The Women,s Health and Cancer ... breast reconstruction following a mastectomy. Still, most women ...
(Date:8/20/2014)... deploy Ebola vaccines is now, Free content, The ... to a commentary being published early online today in ... authors from Yale School of Public Health write that ... current Ebola outbreak represent a public health crisis that ... Ebola vaccines have been developed in the last decade, ...
(Date:8/20/2014)... Barbara Bronson Gray ... -- Although it,s extremely rare, colds, flu and other ... elevated risk for stroke in children, a new study suggests. ... a stroke in the United States, said Dr. Heather Fullerton, ... and pediatrics at the University of California, San Francisco Benioff ...
(Date:8/20/2014)... HealthDay Reporter WEDNESDAY, Aug. 20, ... grow may help doctors diagnose and treat the most aggressive ... found that the deadliest skin cancers occur most often on ... history of sun exposure. These lesions also grow quickly ... growth -- called "high mitotic rate" -- is associated ...
(Date:8/20/2014)... Park Cities Pet Sitter , Inc. has announced ... donation drive that benefits the animal shelter and rescue communities. ... with the Humane Society of the United States’ Animal Shelter ... , As part of their participation, Park Cities Pet Sitter ... the Presents 4 Pets drive from their client base, as ...
Breaking Medicine News(10 mins):Health News:Patient perspectives on breast reconstruction following mastectomy 2Health News:News from Annals of Internal Medicine 2Health News:Study Ties Colds, Flu to Rare Risk of Stroke in Kids 2Health News:Study Ties Colds, Flu to Rare Risk of Stroke in Kids 3Health News:High-Risk Melanomas Often on Head or Neck, Study Finds 2Health News:High-Risk Melanomas Often on Head or Neck, Study Finds 3Health News:Dallas-based Park Cities Pet Sitter Announces Participation in the 2014 National Association of Professional Pet Sitters “Presents 4 Pets” Program 2Health News:Dallas-based Park Cities Pet Sitter Announces Participation in the 2014 National Association of Professional Pet Sitters “Presents 4 Pets” Program 3Health News:Dallas-based Park Cities Pet Sitter Announces Participation in the 2014 National Association of Professional Pet Sitters “Presents 4 Pets” Program 4
... Inc.,(NYSE: HSP ), a leading global hospital products ... executive officer, will make,a formal presentation at the Bear ... in New York City. The presentation will be ... Tuesday, Sept. 11, 2007, through a live audiocast on ...
... habits to prevent vision problems , FRIDAY, Aug. 31 (HealthDay ... their back-to-school checklist: an eye check for their children and ... eye strain. , One out of two children spends more ... screen, according to the American Optometric Association (AOA). But, the ...
... and Diabetes-Friendly, Recipes at the 34th ... Kidney Patients Meeting, ST. LOUIS, Aug. 31 ... that Katie will be,conducting a cooking demonstration at the ... St. Louis, Mo. this afternoon for,patients with chronic kidney ...
... (WorldHeart) (Nasdaq: WHRT , TSX: WHT), a ... appointment of,Mr. David Pellone as Vice President, Finance ... CFO, will provide consulting services,through the end of ... with certain,specific projects. Mr. Pellone is an ...
... VANCOUVER, Aug. 31 /PRNewswire-FirstCall/ - QLT USA, Inc., ... TSX: QLT), announced today that the European,approval procedure ... completed. Launch of this formulation in 23 European ... positive decision in each,of the individual countries. The ...
... Calif., Aug. 30 Caregivers at Antelope,Valley Hospital, represented ... their first union contract with Antelope Valley,Hospital. The ... a vote of,92.25 percent YES to 7.04 percent no. ... real gains,for healthcare workers and the patients they care ...
Cached Medicine News:Health News:Hospira to Present at the Bear Stearns 20th Annual Healthcare Conference on September 11 2Health News:Computer-Related Eye Strain Not Just for Adults 2Health News:Katie Lee Joel to Conduct Cooking Demonstration for Local Patients With Chronic Kidney Disease 2Health News:Katie Lee Joel to Conduct Cooking Demonstration for Local Patients With Chronic Kidney Disease 3Health News:Katie Lee Joel to Conduct Cooking Demonstration for Local Patients With Chronic Kidney Disease 4Health News:Katie Lee Joel to Conduct Cooking Demonstration for Local Patients With Chronic Kidney Disease 5Health News:Katie Lee Joel to Conduct Cooking Demonstration for Local Patients With Chronic Kidney Disease 6Health News:Katie Lee Joel to Conduct Cooking Demonstration for Local Patients With Chronic Kidney Disease 7Health News:WorldHeart Appoints David Pellone Chief Financial Officer 2Health News:Eligard(R) six-month formulation successfully completes European approval procedure 2Health News:Eligard(R) six-month formulation successfully completes European approval procedure 3Health News:UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West 2
(Date:8/20/2014)... 20, 2014 Research and Markets ... "Global Biosimilars/Follow-on-Biologics Market (Technology, Types, Applications, Services and ... report to their offering. A ... and geography) - Size, Share, Global Trends, Company ... and Forecast, 2013 - 2020", suggests that the ...
(Date:8/20/2014)... , August 20, 2014 ... report titled "Monochloroacetic Acid (MCA) Market for Cellulosics, Agrochemicals, ... Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 ... at USD 817.1 million in 2013 and is anticipated ... a CAGR of 3.6% during the forecast period from ...
(Date:8/20/2014)... -- Research and Markets has announced ... Care and Closure Market (Types, Applications, End User ... Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation ... their offering. The new report ... (types, applications, end user and geography) - Size, ...
Breaking Medicine Technology:Global Biosimilars/Follow-on-Biologics Market (Technology, Types, Applications, Services and Geography) - Research Report, 2013 - 2020 2Global Monochloroacetic Acid (MCA) Market is Expected to Reach USD 1,046.7 million by 2020: Transparency Market Research 2Global Monochloroacetic Acid (MCA) Market is Expected to Reach USD 1,046.7 million by 2020: Transparency Market Research 3Global Monochloroacetic Acid (MCA) Market is Expected to Reach USD 1,046.7 million by 2020: Transparency Market Research 4Global Advanced Wound Care and Closure Market (Types, Applications, End User and Geography) - Forecast to 2020 2
... indicates that anti-inflammatory drugs may become a new tool ... leading global cause of death. In investigating a specific ... researchers used the Cardiochip, a gene analysis tool designed ... Center for Applied Genomics at The Children,s Hospital of ...
... March 14, 2012 OncoSec Medical Incorporated ... Medical System (OMS) ElectroOncology therapies to treat solid ... Institute in Santa Monica, CA, and Lakeland Comprehensive ... as enrolling sites, and investigators are screening patients ...
Cached Medicine Technology:Gene Chip, Invented by Children's Hospital of Philadelphia Scientist, Pinpoints New Target to Prevent Heart Disease 2Gene Chip, Invented by Children's Hospital of Philadelphia Scientist, Pinpoints New Target to Prevent Heart Disease 3OncoSec Initiates Two Additional Clinical Sites for Phase II Metastatic Melanoma Trial 2OncoSec Initiates Two Additional Clinical Sites for Phase II Metastatic Melanoma Trial 3OncoSec Initiates Two Additional Clinical Sites for Phase II Metastatic Melanoma Trial 4
... The 5mm AEM Laparoscopic Instruments incorporate a ... Instruments are shielded and monitored to prevent ... the instrument caused by insulation failure or ... The protective shield built into all AEM ...
SOLOS Endoscopy shares your commitment to provide every patient with the highest quality care available through our ongoing research and development of advanced surgical instruments and diagnostic so...
SOLOS Endoscopy shares your commitment to provide every patient with the highest quality care available through our ongoing research and development of advanced surgical instruments and diagnostic so...
... The Featured Products ... at Mediflex and are ... modular in regular or ... come equipped with insulation, ...
Medicine Products: